cupric chloride 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 4530 | 7447-39-4 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
Legend: OFP - off patent OFM - off market ONP - on patent |
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| June 26, 1986 | FDA | HOSPIRA |
FDA Adverse Event Reporting System (Female)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Kounis syndrome | 62.30 | 32.85 | 10 | 261 | 1720 | 63487031 |
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Kounis syndrome | 55.99 | 31.31 | 10 | 249 | 4272 | 79739857 |
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| CHEBI has role | CHEBI:86385 | Delta(7)-cholestenol Delta(7)-Delta(8)-isomerase inhibitors |
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Wilson's disease | contraindication | 88518009 |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| D03612 | KEGG_DRUG |
| 4018533 | VUID |
| N0000146855 | NUI |
| 4017668 | VANDF |
| 4018533 | VANDF |
| CHEBI:49553 | CHEBI |
| CUL | PDB_CHEM_ID |
| CHEMBL1200553 | ChEMBL_ID |
| C029892 | MESH_SUPPLEMENTAL_RECORD_UI |
| DB09131 | DRUGBANK_ID |
| S2QG84156O | UNII |
| 21833 | RXNORM |
| 3685 | MMSL |
| 37993 | MMSL |
| 4512 | MMSL |
| 000854 | NDDF |
| C0056593 | UMLSCUI |
| 24014 | PUBCHEM_CID |
| 10125-13-0 | SECONDARY_CAS_RN |
Pharmaceutical products:
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| COPPER | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0409-4092 | INJECTION, SOLUTION | 0.40 mg | INTRAVENOUS | NDA | 21 sections |
| COPPER | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0409-4092 | INJECTION, SOLUTION | 0.40 mg | INTRAVENOUS | NDA | 21 sections |
| CUPRIC CHLORIDE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51754-0103 | INJECTION, SOLUTION | 0.40 mg | INTRAVENOUS | ANDA | 21 sections |